Paper 2: EUROCAT public health indicators for congenital anomalies in Europe

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue SUPPL. 1, 2011, Pages

  Khoshnood, Babak ^a,b   Greenlees, Ruth ^c   Loane, Maria ^c   Dolk, Helen ^c  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Congenital anomalies; Indicators; Perinatal mortality; Prenatal diagnosis; Public health

Indexed keywords

CONGENITAL MALFORMATION; DOWN SYNDROME; EUROPE; FETUS DEATH; FETUS MALFORMATION; HUMAN; NEURAL TUBE DEFECT; NEWBORN DEATH; PEDIATRIC SURGERY; PERINATAL MORTALITY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; REGISTER; REVIEW; STILLBIRTH;

ABORTION, EUGENIC; CONGENITAL ABNORMALITIES; DOWN SYNDROME; EUROPE; FEMALE; FETAL DEATH; HEALTH STATUS INDICATORS; HUMANS; MALTA; NEURAL TUBE DEFECTS; PERINATAL MORTALITY; PREGNANCY; PRENATAL DIAGNOSIS; PUBLIC HEALTH; REGISTRIES; STILLBIRTH; UKRAINE;

EID: 79952683299     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20776     Document Type: Review

References (8)

1. Bonnet D, Coltri A, Butera G, et al. 1999. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 99: 916-918.
2. Boyd PA, Devigan C, Khoshnood B, et al. 2008. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 115: 689-696.
3. de Hollander AE, Melse JM, Lebret E, Kramers PG. 1999. An aggregate public health indicator to represent the impact of multiple environmental exposures. Epidemiology 10: 606-617.
4. Ezzati M, Lopez AD, Rodgers A, et al. 2002. Selected major risk factorsand global and regional burden of disease. Lancet 360: 1347-1360.
5. Garne E, Khoshnood B, Loane M, et al. 2010. Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European register-based study. BJOG 117: 660-666.
6. Khoshnood B, De Vigan C, Vodovar V, et al. 2005. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 115: 95-101.
7. Murray CJ, Lopez AD. 1997. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442.
8. Rare Diseases Task Force Working Group on Health Indicators. 2010. Health indicators for rare diseases: conceptual framework and development of indicators from existing sources.